Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Inflammation drug therapy"" wg kryterium: Temat


Tytuł :
Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations.
Autorzy :
Letendre, Scott L.
Ellis, Ronald J.
Oliveira, Michelli F.
Chaillon, Antoine
Nakazawa, Masato
Vargas, Milenka
Strain, Matthew C.
Morris, Sheldon
Little, Susan J.
Smith, Davey M.
Gianella, Sara
Pokaż więcej
Temat :
RC581-607
Neurosciences
HIV Infections
Mental Health
Infectious Diseases
Immunologic diseases. Allergy
Retroviruses
Vaccination and Immunization
Pediatric
Artificial Gene Amplification and Extension
HIV-1
HIV
Viral/cerebrospinal fluid Secondary Prevention
Public and Occupational Health
Molecular Biology Techniques
DNA
CD4-Positive T-Lymphocytes
Immunology
Cognitive Dysfunction
2.1 Biological and endogenous factors
Lentivirus
Viruses
Highly Active
Biology and Life Sciences
Secondary Prevention
RNA
Biomarkers
Physiology
Body Fluids
Central Nervous System
Viral Pathogens
RNA viruses
Clinical Research
Cerebrospinal Fluid
Organisms
Viral
Adult
Male
Molecular Biology
Microbial Pathogens
Infection
Research Article
Diagnostic Medicine
Viral/*blood/*cerebrospinal fluid/genetics HIV Infections/*drug therapy/pathology HIV-1/*genetics/physiology Humans Inflammation/drug therapy Leukocytes
Anatomy
Antiretroviral Therapy
Signs and Symptoms
Preventive Medicine
Pathology and Laboratory Medicine
Mononuclear/cytology Male Prospective Studies RNA
Immunodeficiency Viruses
Genetics
Pathogens
Immune Response
Inflammation
Leukocytes
Antiviral Therapy
Polymerase Chain Reaction
Mononuclear
Cognition
Research and Analysis Methods
Microbiology
Blood
Viral diseases
Pediatric AIDS
QH301-705.5
Medical Microbiology
Hematology
Nervous System
Highly Active/*methods Biomarkers/blood/*cerebrospinal fluid CD4-Positive T-Lymphocytes/virology Central Nervous System/*virology Cognition Cognitive Dysfunction/*virology DNA
Virology
Prospective Studies
Adult Antiretroviral Therapy
HIV/AIDS
Medicine and health sciences
Humans
Biology (General)
Źródło :
PLoS Pathogens, Vol 13, Iss 1, p e1006112 (2017)
PLoS pathogens, vol 13, iss 1
Oliveira, MF; Chaillon, A; Nakazawa, M; Vargas, M; Letendre, SL; Strain, MC; et al.(2017). Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations. PLoS Pathogens, 13(1), e1006112. doi: 10.1371/journal.ppat.1006112. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/1942p4bh
Opis pliku :
application/pdf
Tytuł :
Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity
Autorzy :
Pepin, Marion
Mezouar, Soraya
Pegon, Julie
Muczynski, Vincent
Adam, Frédéric
Bianchini, Elsa P
Bazaa, Amine
Proulle, Valerie
Rupin, Alain
Paysant, Jerome
Panicot-Dubois, Laurence
CHRISTOPHE, OLIVIER D.
Dubois, Christophe
Lenting, Peter J
Denis, Cécile V
Pokaż więcej
Temat :
E-SELECTIN LIGAND-1
VON-WILLEBRAND-FACTOR
P-SELECTIN
GLYCOPROTEIN LIGAND
MYELOID CELLS
CD33-RELATED SIGLECS
IMMUNE-SYSTEM
NEUTROPHILS
IN-VIVO
SIALIC-ACID
MESH: Animals
MESH: Anti-Inflammatory Agents/pharmacology
MESH: Antigens, Differentiation, Myelomonocytic/pharmacology
MESH: Disease Models, Animal
MESH: Leukocyte Rolling/physiology
MESH: E-Selectin/metabolism
MESH: Humans
MESH: Inflammation/chemically induced
MESH: Inflammation/drug therapy
MESH: Inflammation/pathology
MESH: Lectins/genetics
MESH: Lectins/metabolism
MESH: Protein Interaction Domains and Motifs
MESH: Lectins/pharmacology
MESH: Leukocytes, Mononuclear/drug effects
MESH: Antigens, CD/genetics
MESH: Leukocytes, Mononuclear/metabolism
MESH: Membrane Glycoproteins/genetics
MESH: Membrane Glycoproteins/metabolism
MESH: Mice, Inbred C57BL
MESH: P-Selectin/metabolism
MESH: Solubility
MESH: Female
MESH: Tumor Necrosis Factor-alpha/toxicity
MESH: Antigens, CD/metabolism
MESH: Antigens, CD/pharmacology
MESH: Antigens, Differentiation, Myelomonocytic/genetics
MESH: Antigens, Differentiation, Myelomonocytic/metabolism
[SDV]Life Sciences [q-bio]
Źródło :
Scientific Reports, Nature Publishing Group, 2016, 6 (1), pp.37953. ⟨10.1038/srep37953⟩
Tytuł :
Shaping mycolactone for therapeutic use against inflammatory disorders
Autorzy :
Guenin-Mace, Laure
Baron, Ludivine
Chany, Anne-Caroline
Tresse, Cédric
Saint-Auret, Sarah
Jönsson, Friederike
Le Chevalier, Fabien
Bruhns, Pierre
Bismuth, Georges
Hidalgo-Lucas, Sophie
Bisson, Jean-François
Blanchard, Nicolas
Demangel, Caroline
Pokaż więcej
Temat :
MESH: Animals
MESH : Pain/complications
MESH: Inflammation/drug therapy
[SDV.IMM]Life Sciences [q-bio]/Immunology
MESH : Animals
MESH: Jurkat Cells
[SDV] Life Sciences [q-bio]
MESH : HeLa Cells
MESH: Mycobacterium ulcerans/physiology
MESH : Protective Agents/therapeutic use
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
MESH: Inflammation/pathology
[SDV.BC] Life Sciences [q-bio]/Cellular Biology
[SDV.BDD]Life Sciences [q-bio]/Development Biology
MESH : Pain/drug therapy
MESH: Protective Agents/therapeutic use
MESH: Immunomodulation
MESH: HeLa Cells
MESH : Jurkat Cells
MESH : Inflammation/drug therapy
[SDV.IMM] Life Sciences [q-bio]/Immunology
MESH : Mycobacterium ulcerans/physiology
MESH: Tetradecanoylphorbol Acetate/pharmacology
[SDV.BDD] Life Sciences [q-bio]/Development Biology
MESH: Pain/drug therapy
MESH: Humans
MESH : Tetradecanoylphorbol Acetate/pharmacology
MESH : Immunomodulation
MESH : Macrolides/therapeutic use
MESH: Pain/complications
MESH: Mice
MESH : Macrolides/chemistry
MESH : Chronic Disease
MESH : Inflammation/pathology
MESH : Humans
[SDV]Life Sciences [q-bio]
MESH: Chronic Disease
MESH: Macrolides/chemistry
MESH: Macrolides/therapeutic use
MESH : Mice
Źródło :
Science Translational Medicine
Science Translational Medicine, American Association for the Advancement of Science, 2015, 7 (289), pp.289ra85 - 289ra85. 〈10.1126/scitranslmed.aab0458〉
Science Translational Medicine, American Association for the Advancement of Science, 2015, 7 (289), pp.289ra85 - 289ra85. ⟨10.1126/scitranslmed.aab0458⟩
Tytuł :
Compound 21, a selective agonist of angiotensin AT 2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo
Autorzy :
Sampson, Amanda K
Irvine, Jennifer C
Shihata, Waled A
Dragoljevic, Dragana
Lumsden, Natalie
Huet, Olivier
Barnes, Tyrone
Unger, Thomas
Steckelings, Ulrike Muscha
Jennings, Garry L
Widdop, Robert E
Chin-Dusting, Jaye Pf
Pokaż więcej
Temat :
Animals
Apolipoproteins E/deficiency
Cell Adhesion/drug effects
Cells, Cultured
Human Umbilical Vein Endothelial Cells/drug effects
Humans
Inflammation/drug therapy
Leukocytes/cytology
Male
Mice
Mice, Knockout
Reactive Oxygen Species/metabolism
Receptor, Angiotensin, Type 2/agonists
Signal Transduction/drug effects
Sulfonamides/chemistry
Thiophenes/chemistry
Źródło :
Sampson, A K, Irvine, J C, Shihata, W A, Dragoljevic, D, Lumsden, N, Huet, O, Barnes, T, Unger, T, Steckelings, U M, Jennings, G L, Widdop, R E & Chin-Dusting, J P 2016, ' Compound 21, a selective agonist of angiotensin AT 2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo ', British Journal of Pharmacology, vol. 173, no. 4, pp. 729-740 . https://doi.org/10.1111/bph.13063
Tytuł :
Subconjunctival Injection of XG-102, a JNK Inhibitor Peptide, in Patients with Intraocular Inflammation: A Safety and Tolerability Study.
Autorzy :
Beydoun, Talal
Deloche, Catherine
Perino, Julien
Kirwan, Bridget-Anne
Combette, Jean-Marc
Behar-Cohen, Francine
Pokaż więcej
Temat :
MAP Kinase Kinase 4/antagonists & inhibitors
MAP Kinase Kinase 4/metabolism
Eye Diseases/enzymology
Eye Diseases/drug therapy
Eye Diseases/blood
Inflammation/enzymology
MAP Kinase Signaling System/drug effects
Peptides/blood
Inflammation/drug therapy
Peptides/adverse effects
Postoperative Complications/drug therapy
Inflammation/blood
Peptides/administration & dosage
Źródło :
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics 31(2) 93-99
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics, vol. 31, no. 2, pp. 93-9
Opis pliku :
application/pdf

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies